Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Goo-yeong H. Cho

Seoul, KR 
Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Seoul, KR 
OverviewLocationsClinical Research

Overview

Goo-yeong Cho practices in Seoul, Republic of Korea. Cho is rated as an Advanced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Their top areas of expertise are Hypertensive Heart Disease, Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Heart Failure, and Percutaneous Coronary Intervention (PCI).

Their clinical research consists of co-authoring 209 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 12 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Locations

Seoul, Republic of Korea
Other Locations
Gyeonggi-do, Republic of Korea
Songnam, Republic of Korea
Gwangju, Republic of Korea
Ochang, Republic of Korea
Pohang, 790784, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Double-blind, Placebo-controlled, Stratified-randomized, Parallel, Therapeutic Exploratory Clinical Study to Evaluate the Efficacy and Safety of DA-1229 in Patients With Calcific Aortic Valve Disease
A Multicenter, Double-blind, Placebo-controlled, Stratified-randomized, Parallel, Therapeutic Exploratory Clinical Study to Evaluate the Efficacy and Safety of DA-1229 in Patients With Calcific Aortic Valve Disease
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug
Study Drug: DA-1229
Study Phase: Phase 2

209 Total Publications

Left Ventricular Mass-to-Strain Ratio to Predict Change in Left Ventricular Hypertrophy and Prognosis in Hypertensive Heart Disease.
Left Ventricular Mass-to-Strain Ratio to Predict Change in Left Ventricular Hypertrophy and Prognosis in Hypertensive Heart Disease.
Journal: Journal of the American Heart Association
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Cho's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 31 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile